Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Structurally, tirzepatide is derived primarily from the sequence of the endogenous incretin hormone GIP, with several targeted amino acid substitutions incorporated to enhance receptor interaction and structural stability within experimental systems
Weight-loss benefit builds as the dose climbs toward the 2.4 mg maintenance target
The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes
Results vary depending on several factors, including: starting body weight dosage consistency nutrition habits sleep activity level underlying metabolic health Some people notice gradual, steady fat loss, while others experience more dramatic changes after dosage increases
Compounded versions are not the same as branded Ozempic, Wegovy, Mounjaro, or Zepbound
US$ 22.42
US$ 27.75
US$ 25.36
US$ 21.49
